The Ocular Melanoma Foundation (OMF) is the leading resource for eye cancer research funding and patient/caregiver support. OMF has raised over a million dollars in its quest to #SEEACURE for eye cancer and every year hosts the largest gathering of OM patients in the world.


  • OMF's strategic partner, Aura Biosciences, recently received clearance from the U.S. FDA to conduct a clinical trial using targeted therapy. This study for light-activated AU-011 for the treatment of patients with small-to-medium primary ocular melanoma is now enrolling in five locations across the country. To learn more, visit or contact

Raising Awareness of Eye Health

Strategic Partners